Poseida Therapeutics, Inc.

NASDAQ:PSTX

3.51 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42017 Q4
Operating Activities:
Net Income -31.371-24.274-25.349-31.778-27.456-38.847-33.31870.409-43.036-58.0571.469-42.424-45.705-38.314-36.148-34.415-30.428-28.784-23.613-20.953-28.627-13.334-12.89-4.791
Depreciation & Amortization 1.3491.381.4381.4441.4081.3241.3551.351.261.2071.1831.1691.1281.0721.040.6870.4430.4160.3860.3470.2590.2010.1530.174
Deferred Income Tax 003.989-3.9920.00300000-19.7680.0170.0690.05-0.1740.1880.219-0.02-0.02900.7830.0300
Stock Based Compensation 7.6295.3835.0635.1175.4747.484.5484.2775.2344.8674.3494.1514.7423.4622.21.8951.6161.5091.3130.6760.6070.4540.3790.106
Change In Working Capital 62.2034.003-7.96238.857-10.818-5.99630.769-12.2291.321-6.14621.085-3.9378.514-5.4942.62.156-2.8833.755.202-0.5715.248-0.412-0.8161.255
Accounts Receivables -0.4-3.016-0.3383.233-3.4680.6529.379-38.235-0.232000000.137000000000
Change In Inventory 00-4.4920.2874.2050000000002.734000000000
Change In Accounts Payables 0.286-0.5630.7360.433-1.0970.966-1.2120.323-0.468-5.3914.96-0.8452.0071.72-0.192-0.325-3.556-0.0982.573-2.4561.861-0.44800
Other Working Capital 62.3177.582-8.3634.904-10.458-7.6122.60225.6832.021-0.75516.125-3.0926.507-7.214-0.0792.4810.6733.8482.6291.8853.3870.036-0.8161.255
Other Non Cash Items 9.08110.0955.607-1.76-1.917-1.966-0.951-1.929-4.5086.8050.1550.1520.1640.1680.1670.1620.2320.2440.3051.3317.609-1.6020.964-1.557
Operating Cash Flow 38.45-15.135-28.7447.888-33.306-38.0052.40361.878-39.729-51.3248.473-40.872-31.088-39.056-30.315-29.327-30.801-22.885-16.436-19.17-14.121-14.663-12.21-4.813
Investing Activities:
Investments In Property Plant And Equipment -1.019-0.13-0.309-0.789-1.184-0.784-0.26-1.703-1.218-0.743-0.213-0.365-1.581-0.475-2.152-2.801-8.439-3.516-1.387-1.817-1.686-0.266-0.633-0.024
Acquisitions Net 0040.6260-44.2573.63185.630.012000.0180000000000000
Purchases Of Investments -102.683-53.367-21.978-106.448-55.743-53.631-150.63-64.181-79.611000000.124-275.2630.073-19.957-4.94-47.844-18.652000
Sales Maturities Of Investments 42.577.5706010050653000037.562.512550202017.516.517.50000
Other Investing Activites -60.18324.13348.022-46.44844.257-3.631-85.63-34.169-79.61100.01837.562.512550.124-255.26320.073-2.45711.688-30.344-18.652000
Investing Cash Flow -61.20224.00347.713-47.23743.073-4.415-85.89-35.872-80.829-0.743-0.19537.13560.919124.52547.972-258.06411.634-5.97310.173-32.161-20.338-0.266-0.633-0.024
Financing Activities:
Debt Repayment 000000-1.4490-1.45-28.550000-0.329000000-1000
Common Stock Issued 00.549-14.06914.41700.9280.07575.8380.0320.6810.2361.8550.0670.360000000000
Common Stock Repurchased 0-0.5920.49400-0.494000000000000000000
Dividends Paid 000000000000000000000000
Other Financing Activities 0-0.59213.5750.52400.7521.43175.8381.48228.550.2361.8550.0670.360.367206.529103.0284.3460.0147.86360.57595.9194.704-0.108
Financing Cash Flow 0-0.04394.81714.94101.1860.05875.8380.03229.2310.2361.8550.0670.360.038206.529103.0284.3460.0147.86360.57595.9194.704-0.108
Other Information:
Effect Of Forex Changes On Cash 00-94.81794.817000000-42,961.5990000000000000
Net Change In Cash -22.7528.82518.969-24.4089.767-41.234-83.429101.844-120.526-22.8368.514-1.88229.89885.82917.695-80.86283.861-24.512-6.249-43.46826.11680.99-8.139-4.945
Cash At End Of Period 30.54553.29744.47225.50349.91140.14481.378164.80762.963183.489206.325197.811199.693169.79583.96666.271147.13363.27287.78494.033137.501111.38530.39515.625